SDGR NASDAQ
Schrödinger, Inc.
1W: +14.2%
1M: -9.4%
3M: +76.7%
YTD: +48.6%
1Y: +18.6%
3Y: +21.6%
5Y: -52.0%
$26.72
+2.22 (+9.06%)
Pre-Market: $26.80 (+0.09, +0.32%)
Weekly Expected Move ±11.3%
$18
$21
$24
$26
$29
Credit Risk of going bust: lower than 56% of companies Debt: 5.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.18 (down 99.3%), Schrödinger, Inc. would be worth roughly what it owes.
Total debt $108.0M against a stock market value of $2.00B.
Distance to default 5.78 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $54.0M (short-term plus half of long-term), stock volatility 62.1%; Altman Z'' 0.13. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.18 (down 99.3%), Schrödinger, Inc. would be worth roughly what it owes.
Total debt $108.0M against a stock market value of $2.00B.
Distance to default 5.78 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $54.0M (short-term plus half of long-term), stock volatility 62.1%; Altman Z'' 0.13. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
2 relationships2
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2024-02-29
Earliest Filing
2024-11-12
Latest Filing
partner: 2
Counterparties (Filed by SDGR)
2 relationshipsCompanies named in SDGR's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Novartis Pharma AG | NVSEF | partner | Research collaboration and license agreement for discovery and pre-clinical development of small molecule compounds | 2024-11-12 | View |
| Leerink Partners LLC | — | partner | Sales agent for the amended and restated sales agreement allowing the Company to offer and sell shares of common stock. | 2024-02-29 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-05 | Earnings Release; Exhibits | View | |
| 2026-06-29 | Regulation FD | View | |
| 2026-06-23 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-06-08 | Officer/Director Change; Exhibits | View | |
| 2026-05-20 | Officer/Director Change; Regulation FD | View | |
| 2026-05-05 | Earnings Release; Exhibits | View | |
| 2026-03-12 | Departure/Election of Directors; Appointment of Officers | View | |
| 2026-02-25 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-11-05 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-09-08 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-08-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-18 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-20 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-05-19 | Other Events | View | |
| 2025-05-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-11 | Other Events; Financial Statements and Exhibits | View | |
| 2025-03-10 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-02-26 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-11-12 | Entry into Material Definitive Agreement | Agreement | View |
| 2024-11-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR